These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20215525)

  • 1. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
    Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
    Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
    Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
    Tarhan YE; Kato T; Jang M; Haga Y; Ueda K; Nakamura Y; Park JH
    Neoplasia; 2016 May; 18(5):265-272. PubMed ID: 27237318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1.
    Gao F; Zheng G
    Dis Markers; 2022; 2022():2959846. PubMed ID: 35909886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway.
    Mao Y; Zhang Y; Fan S; Chen L; Tang L; Chen X; Lyu J
    Int J Biol Sci; 2019; 15(1):169-182. PubMed ID: 30662357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer.
    Brooks SA; Carter TM; Bennett EP; Clausen H; Mandel U
    Acta Histochem; 2007; 109(4):273-84. PubMed ID: 17448526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
    Park JH; Katagiri T; Chung S; Kijima K; Nakamura Y
    Neoplasia; 2011 Apr; 13(4):320-6. PubMed ID: 21472136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
    Berois N; Mazal D; Ubillos L; Trajtenberg F; Nicolas A; Sastre-Garau X; Magdelenat H; Osinaga E
    J Histochem Cytochem; 2006 Mar; 54(3):317-28. PubMed ID: 16260590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M.
    Liu C; Li Z; Xu L; Shi Y; Zhang X; Shi S; Hou K; Fan Y; Li C; Wang X; Zhou L; Liu Y; Qu X; Che X
    Aging (Albany NY); 2020 Jun; 12(12):11794-11811. PubMed ID: 32559179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition.
    Lin J; Chung S; Ueda K; Matsuda K; Nakamura Y; Park JH
    Neoplasia; 2017 Jan; 19(1):43-53. PubMed ID: 28110670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase.
    Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC
    Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.
    Lin TC; Chen ST; Huang MC; Huang J; Hsu CL; Juan HF; Lin HH; Chen CH
    Oncotarget; 2017 Jun; 8(26):42588-42601. PubMed ID: 28388560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines.
    Paszkiewicz-Gadek A; Porowska H; Lemancewicz D; Wolczynski S; Gindzienski A
    Int J Mol Med; 2006 Apr; 17(4):669-74. PubMed ID: 16525726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.
    Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J
    Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
    Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC
    Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines.
    Kondo K; Kohno N; Yokoyama A; Hiwada K
    Cancer Res; 1998 May; 58(9):2014-9. PubMed ID: 9581847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
    Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
    Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
    Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
    Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
    Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.